Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Androgenetic alopecia
ADR ID BADD_A06488
ADR Hierarchy
05      Endocrine disorders
05.05      Endocrine disorders of gonadal function
05.05.04      Endocrine abnormalities of gonadal function NEC
05.05.04.001      Androgenetic alopecia
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.02      Alopecias
23.02.02.002      Androgenetic alopecia
Description Absence of hair from areas where it is normally present. [MeSH]
MedDRA Code 10068168
MeSH ID D000505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Female pattern baldness | Female pattern hair thinning | Male pattern baldness | Androgenetic alopecia | Androgenic alopecia | Alopecia | Baldness | Hair Loss | Hair Losses | Loss, Hair | Losses, Hair | Alopecia, Male Pattern | Male Pattern Alopecia | Baldness, Male Pattern | Male Pattern Baldness | Female Pattern Baldness | Baldness, Female Pattern | Androgenetic Alopecia | Pattern Baldness | Baldness, Pattern | Androgenic Alopecia | Alopecia, Androgenic | Alopecias, Androgenic | Androgenic Alopecias | Alopecia, Androgenetic | Pseudopelade | Alopecia Cicatrisata | Alopecia Cicatrisatas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00142Anastrozole0.000540%
BADD_D00680Dimethyl fumarate0.000880%
BADD_D00898Finasteride0.000099%
BADD_D00934Fluoxymesterone--
BADD_D01257Letrozole0.000659%
BADD_D01438Methyltestosterone--
BADD_D01530Nandrolone decanoate--
BADD_D01634Oxandrolone--
BADD_D01647Oxymetholone--
BADD_D02170Testosterone--
BADD_D02171Testosterone cypionate--
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
The 1th Page    1    Total 1 Pages